Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Therapeutic Drug Monitoring
100%
Pragmatic Clinical Trial
100%
Linezolid
100%
Rifampicin-resistant Tuberculosis (RR-TB)
100%
Rifampicin Resistance
29%
South Africa
21%
Standard of Care
14%
Drug-resistant Tuberculosis (DR-TB)
14%
Premature Discontinuation
8%
Survival Rate
7%
Narrow Therapeutic Window
7%
Tuberculosis Control
7%
New Drugs
7%
Antituberculosis Activity
7%
Treatment Failure
7%
Global Burden
7%
Global Epidemic
7%
Additional Resistance
7%
Treatment Regimen
7%
Trough Plasma Concentration
7%
Trough Concentration
7%
Drug-resistant HIV
7%
TB Drugs
7%
Drug Toxicity
7%
Effective Compounds
7%
Clinical Adverse Events
7%
Drug Efficacy
7%
Inter-individual Variability
7%
Gram-positive
7%
Therapy Discontinuation
7%
Pharmacology
7%
HIV Control
7%
Control Effort
7%
Mycobacterium Tuberculosis (M. tb)
7%
Dose Reduction
7%
Multidrug
7%
Myelosuppression
7%
Cure Rate
7%
Tuberculosis Treatment
7%
Pharmacokinetic Parameters
7%
Drug Standards
7%
Population PK
7%
Excess Mortality
7%
TB Therapy
7%
Repurposed Medications
7%
Extensively Drug-resistant
5%
Hematologic
5%
Medicine and Dentistry
Therapeutic Drug Monitoring
100%
Linezolid
100%
Rifampicin
100%
Drug Resistant Tuberculosis
100%
Randomized Controlled Trial
100%
Human Immunodeficiency Virus
21%
Arm
21%
Republic of South Africa
21%
Tuberculosis
14%
Prematurity
10%
Bone Marrow Suppression
7%
Randomized Clinical Trials
7%
Therapeutic Window
7%
Drug Toxicity
7%
Epidemic
7%
Drug Dose Reduction
7%
Mortality Rate
7%
Tuberculosis Treatment
7%
Pharmacokinetics
7%
Drug Efficacy
7%
Adverse Event
7%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Controlled Trial
100%
Therapeutic Drug Monitoring
100%
Linezolid
100%
Drug Resistant Tuberculosis
100%
Rifampicin
100%
HIV
21%
Tuberculosis
21%
Prematurity
10%
Mortality Rate
7%
Randomized Clinical Trial
7%
Pharmacokinetic Parameter
7%
Therapeutic Window
7%
Adverse Event
7%
Bone Marrow Suppression
7%
Drug Toxicity
7%
Epidemic
7%